MenüForum-NavigationForumMitgliederAnmeldenRegistrierenForum-Breadcrumbs - Du bist hier:ForumFlohmarkt: AllgemeineskmqacaAntwortenAntworten: kmqaca <blockquote><div class="quotetitle">Zitat von Gast am 31. März 2026, 14:50 Uhr</div>[url=https://www.oncotarget.com/article/4836/]Zoya Demidenko[/url]: Scholar in Cancer Studies [url=https://pubmed.ncbi.nlm.nih.gov/22228887/]Zoya Demidenko[/url] is a recognized scientist affiliated with the Unit of Cell Stress Science at Roswell Park Cancer Institute in Buffalo, New York. Earlier, she conducted research at the NIH and New York Medical College, building a strong foundation in life science study. Demidenko's scholarly contributions covers a number of pivotal fields, encompassing the PI3K/AKT/mTOR signaling cascade, cellular cycle management, biological aging, and tumor biology. Currently, she has authored over 46 academic articles, which have received more than 4,100 citations — a reflection to the significance of her findings. One of her key achievements lies in understanding the mechanisms of cell aging. Her research showed that when the cell cycle is arrested while cellular growth proceeds, cells undergo senescence. Importantly, [url=https://www.tandfonline.com/doi/abs/10.4161/cbt.4.4.1702]Zoya Demidenko[/url] showed that this transition is pharmacologically suppressed using compounds such as rapamycin. [url=https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0026126]Zoya Demidenko[/url] has also contributed substantially to oncological therapy investigation, notably in the field of cyclotherapy — a approach aimed at safeguarding normal tissue from anticancer drugs while leaving malignant cells susceptible. This strategy carries major potential for diminishing the side effects of cancer treatment. Across her professional journey, Demidenko has collaborated with top scientists worldwide, among them Dr. Mikhail Blagosklonny. Her publications appears in prestigious publications such as Oncotarget, Cell Cycle, Aging (Albany NY), and Oncogene. [31.03.2026 11:21] Папа: With an h-index of 33, [url=https://pubmed.ncbi.nlm.nih.gov/22228887/]Zoya Demidenko[/url] stands as a widely cited voice in current oncological research, whose findings go on to influence our comprehension of the way biological cells grow old, respond to therapy, and how cancer can be more successfully targeted. https://www.aging-us.com/article/100406/</blockquote><br> Abbrechen
